Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic
dysfunction encountered in general practice. A large proportion of individuals with type 2 …

Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver
condition in Western World and across the globe. NAFLD prevalence is estimated to be …

Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the leading liver disease globally.
NAFLD patients can have a progressive phenotype, non-alcoholic steatohepatitis (NASH) …

Traditionally a disease of hepatologists, nonalcoholic fatty liver disease (NAFLD) has
recently become a major concern for a broad spectrum of health care providers …

Background: Nonalcoholic fatty liver disease (NAFLD) is emerging as a public health issue
worldwide and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). However …

The global prevalence of non‐alcoholic fatty liver disease (NAFLD) is rising, along with the
epidemic of diabesity. NAFLD is present in> 70% of individuals with type 2 diabetes …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver
diseases worldwide. A strong relationship exists between NAFLD and diabetes mellitus …

Aims To conduct a systematic literature review to identify recent epidemiological, biomarker,
genetic and clinical evidence that expands our understanding of nonalcoholic fatty liver …

Context: Nonalcoholic fatty liver disease (NAFLD) is increasingly diagnosed worldwide and
is the most common chronic liver disease in Western countries. In this review, we discuss the …